Skip to content
Menu

City Of Hope And Adagene Launch Phase 1 Clinical Trial To Explore Combination Therapy For Patients Battling Metastatic Colorectal Cancer

Benzinga Newsdesk 13 hours ago

News

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Study was designed by medical oncologist to accelerate lifesaving care to patientsCity of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc.

Study was designed by medical oncologist to accelerate lifesaving care to patients

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc. ("Adagene") (NASDAQ:ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, particularly for those whose disease has resisted standard treatments.

Read at benzinga.com